.Along with early period 1 data right now out in the wild, metabolic illness ensemble Metsera is act...
.Rivus Pharmaceuticals has actually revealed the information behind its own stage 2 obesity gain in ...
.Bristol Myers Squibb is actually spending Prime Medicine $110 thousand ahead of time to create reag...
.Novartis has actually printer inked an offer possibly worth more than $1 billion with Flagship-foun...
.Just recently debuted Metsera is unfolding some period 1 data for its own GLP-1 receptor agonist, d...
.In the middle of the hereditary medications arms nationality, Flagship Pioneering is actually intro...
.BioAge Labs is actually considering all around $180 million in initial profits coming from an IPO a...
.An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer...
.Spain-based Asabys Partners has shut a fund of 180 million euros ($ 200 thousand), cash that will g...
.BioAge Labs is generating almost $200 million by means of its Nasdaq IPO today, with the profits se...